Company announcement no 2026-10 | 13 August 2026 |
Transactions with Demant shares by managers and closely associated parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Name | Thomas Hofman-Bang |
2. | Reason for the notification | |
a) | Position/status | Member of the Board of Directors |
b) | Initial notification/amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, | |
a) | Name | Demant A/S |
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase |
c) | Price(s) and volume(s) | Price(s) Volume(s)
DKK 288.80 per share 17,224 shares |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 17,224 shares Aggregated price: DKK 4,974,291.20 |
e) | Date of the transaction | 12 August 2026 |
f) | Place of the transaction | Nasdaq Copenhagen A/S |
Further information: Søren Nielsen, President & CEO Phone +45 3917 7300 | Other contacts: René Schneider, CFO Peter Pudselykke, Head of Investor Relations Gustav Høegh, Investor Relations Officer Maribel Alonso Francisco, Communication Manager |
Demant is a world-leading hearing healthcare group that offers innovative technologies, solutions and expertise to help people hear better. In every aspect, from hearing care and hearing aids to diagnostic equipment and services, Demant is active and engaged. Headquartered in Denmark, the Group employs more than 26,000 people globally and is present with solutions in 130 countries creating life-changing differences through hearing health. William Demant Foundation holds the majority of shares in Demant A/S, which is listed on Nasdaq Copenhagen and among the 25 most traded stocks.